Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen- specific Th1 or Th2 cells

Journal of Immunological Methods

Volumn 209, Issue 1, 1997, Pages 85-92

  Ohta, Akio ^a   Sato, Naoko ^a   Yahata, Takashi ^a   Ohmi, Yasushi ^a   Santa, Kazuki ^a   Sato, Takehito ^a   Tashiro, Hiroyuki ^b   Habu, Sonoko ^a   Nishimura, Takashi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fujiya Co Ltd   (Japan)

Author keywords

DTH; IFN ; IL 4; LFA 1; Th1; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; DELAYED HYPERSENSITIVITY; FEMALE; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS; TH2 CELLS;

ANIMALIA;

EID: 0031563948     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00152-X     Document Type: Article

References (38)

1. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of α4 integrin by CD4 T-cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57.
2. Biancone L., Andres G., Ahn H., Lim A., Dai C., Noelle R., Yagita H., De Martino C., Stamenkovic I. Distinct regulatory roles of lymphocyte costimulatory pathways on T-helper type 2-mediated autoimmune disease. J. Exp. Med. 183:1996;1473.
3. Chatelain R., Varkila K., Coffman R.L. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1992;1182.
4. H1 clones. J. Immunol. 138:1987;3688.
5. Corry D.B., Folkesson H.G., Warnock M.L., Erle D.J., Matthay M.A., Wiener-Kronish J.P., Locksley R.M. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:1996;109.
6. Donckier V., Abramowicz D., Bruyns C., Florquin S., Vanderhaeghen M.-L., Amraoui Z., Dubois C., Vandenabeele P., Goldman M. IFN-γ prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J. Immunol. 153:1994;2361.
7. Gautam S.C., Chikkala N.F., Hamilton T.A. Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene. J. Immunol. 148:1992;1411.
8. Gavett S.H., O'Hearn D.J., Li X., Huang S.-K., Finkelman F.D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation and Th2 cytokine expression in mice. J. Exp. Med. 182:1995;1527.
9. Gollob J.A., Li J., Reinherz E.L., Ritz J. CD2 regulates responsiveness of activated T-cells to interleukin 12. J. Exp. Med. 182:1995;721.
10. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T-cell subsets. J. Exp. Med. 169:1989;59.
11. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1993;1505.
12. + T-helper cell phenotype development in a T-cell receptor-αβ-transgenic model. J. Exp. Med. 182:1995;1579.
13. Hsieh C.-S., Heimberger A.B., Gold J.S., O'Garra A., Murphy K.M. Differential regulation of T-helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89:1992;6065.
14. Jardim A., Alexander J., Teh H.S., Ou D., Olafson R.W. Immunoprotective Leishmania major synthetic T-cell epitopes. J. Exp. Med. 172:1990;645.
15. Kennedy M.K., Torrance D.S., Picha K.S., Hohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496.
16. Lenschow D.J., Herold K.C., Rhee L., Patel B., Koons A., Qin H.-Y., Fuchs E., Singh B., Thompson C.B., Bluestone J.A. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 5:1996;285.
17. + T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34.
18. Magram J., Connaughton S.E., Warrier R.R., Daisy M.C., Wu C.-Y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., Gately M.K. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity. 4:1996;471.
19. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153.
20. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145.
21. Mule J.J., Shu S., Schwarz S.L., Rosenberg S.A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science. 225:1984;1487.
22. Murray J.S., Madri J., Pasqualini T., Bottomly K. Functional CD4 T-cell subset interplay in an intact immune system. J. Immunol. 150:1993;4270.
23. Nishimura T., Yagi H., Yagita H., Uchiyama Y., Hashimoto Y. Lymphokine-activated killer cell-mediated cytotoxicity. Cell. Immunol. 94:1985;122.
24. Nishimura T., Togashi Y., Goto M., Yagi H., Uchiyama Y., Hashimoto Y. Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2. Cancer Immunol. Immunother. 21:1986;12.
25. + helper/killer T-cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy. J. Immunol. 148:1992;285.
26. Nishimura T., Sadata A., Yahagi C., Santa K., Otsuki K., Watanabe K., Yahata T., Habu S. The therapeutic effect of interleukin-12 or its antagonist in transplantation immunity. Ann. N. Y. Acad. Sci. 795:1996;371.
27. - T-cells in non-MHC gene controlled predisposition toward skewing into T-helper type-2 immunity in BALB/c mice. J. Immunol. 158:1997;5698.
28. O'Garra A., Murphy K.M. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5:1995;880.
29. Racke M.K., Bonomo A., Scott D.E., Cannella B., Levine A., Raine C.S., Shevach E.M., Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory disease. J. Exp. Med. 180:1994;1961.
30. Röcken M., Racke M., Shevach E.M. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today. 17:1996;225.
31. Sato T., Sasahara T., Nakamura Y., Osaki T., Hasegawa T., Tadakuma T., Arata Y., Kumagai Y., Katsuki M., Habu S. Naive T-cells can mediate delayed-type hypersensitivity response in T-cell receptor transgenic mice. Eur. J. Immunol. 24:1994;1512.
32. Scott B., Liblau R., Degermann S., Marconi L.A., Ogata L., Caton A.J., McDevitt H.O., Lo D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1:1994;73.
33. Scott P., Kaufmann S.H.E. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today. 12:1991;346.
34. Shankar A.H., Titus R.G. T-cell and non-T-cell compartments can independently determine resistance to Leishmania major. J. Exp. Med. 181:1995;845.
35. Simon A.K., Seipelt E., Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA. 91:1994;8562.
36. Sypek J.P., Chung C.L., Mayor S.E.H., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., Schaub R.G. Resolution of cutaneous Leishmaniasis: Interleukin 12 initiates a protective T-helper type 1 immune response. J. Exp. Med. 177:1993;1797.
37. h1-dependent mouse liver injury. Int. Immunol. 8:1996;569.
38. Vercelli D., Jabara H.H., Lauener R.P., Geha R.S. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J. Immunol. 144:1990;570.